Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID07517172

Evaluating Noninvasive Brain Stimulation for TMD Pain: A Feasibility Study

Led by University of Minnesota · Updated on 2026-05-29

40

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the use of Transcutaneous Auricular Neurostimulation (tAN) as a noninvasive treatment for chronic Temporomandibular Disorders (TMD). This randomized, double-blind, sham-controlled feasibility trial aims to assess how acceptable and effective daily home-based tAN sessions are in reducing chronic orofacial pain and improving cognitive and psychosocial functions in adults with TMD. The study will enroll about 40 participants and is designed to gather crucial data to support future larger trials. Participants will be assigned to either an active tAN group or a sham stimulation group. After initial assessments, they will be trained to self-administer the assigned treatment at home daily for at least two hours, with a maximum of 24 hours. The active tAN delivers mild electrical pulses to the auricular branch of the vagus nerve via electrodes on the ear, while the sham device mimics the experience without delivering electrical stimulation. Device usage, adherence, and side effects will be tracked through internal logs. Throughout the study, participants will be monitored for retention, adherence, and acceptability of the intervention at specific time points (weeks 4 and 6). Secondary measures include evaluating pain intensity, cognitive flexibility, and mood using validated scales and wearable smartwatch data. Participants will complete surveys and check-ins electronically, with all data collected to inform the potential of tAN as a non-pharmacological option for managing TMD pain.

CONDITIONS

Brief Title

Evaluating Noninvasive Brain Stimulation for TMD Pain: A Feasibility Study

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 65 years
  • Diagnosis of temporomandibular disorder (TMD) based on Diagnostic Criteria for Temporomandibular Disorders (DC-TMD)
  • Pain intensity of at least 4 out of 10 on the Numeric Rating Scale over the past two weeks
  • Chronic pain lasting at least three months consistent with chronic TMD
  • Willingness to self-administer transcutaneous auricular nerve stimulation (tAN) at home and follow study procedures
  • Fluency in English to understand study materials and assessments
  • Access to a smartphone or computer with internet to complete electronic surveys and check-ins
Not Eligible

You will not qualify if you...

  • Neurological conditions like epilepsy, stroke, multiple sclerosis, or traumatic brain injury
  • Use of implanted neuromodulation devices such as vagus nerve stimulators, deep brain stimulators, or cochlear implants
  • Unstable or severe psychiatric disorders including active psychosis or severe depression with suicidal thoughts
  • Pregnancy or plans to become pregnant during the study
  • Skin conditions or other issues preventing safe electrode placement on the ear
  • History of trauma or surgery near the ear affecting nerve function
  • Use of surgical or non-surgical bone conduction hearing devices

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 4 weeks

Participants are trained to self-administer transcutaneous auricular neurostimulation (tAN) or sham stimulation at home daily for a minimum of two hours, with usage monitored via device logs.

Daily self-administration at home monitored remotely

Follow-up

Duration - 2 weeks

Participants complete assessments on retention, adherence, and acceptability of the intervention.

Electronic surveys and check-ins using smartphone or computer

Trial Site Locations

Total: 1 location

1

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Actively Recruiting

Loading map...

Research Team

C

Carla Campbell

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pa...

Temporomandibular Disorder

Actively Recruiting

1 location

Validity, Reliability and Responsiveness of the Cognitive Ex...

Temporomandibular Disorder

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here